(Q33275854)

25 July 2017

title

Prognostic and Therapeutic Markers in Chordomas: A Study of 287 Tumors (English)

1 reference

25 July 2017

0 references

18

0 references

Bernard George

19

0 references

Homa Adle-Biassette

21

Homa Adle-Biassette

0 references

Annie Laquerrière

13

Marie-Hélène Aubriot-Lorton

Annie Laquerrière

0 references

17

0 references

Franck Monnien

Franck Monnien

11

0 references

Eleonora Aronica

6

Eleonora Aronica

1 reference

25 July 2017

author name string

Arnault Tauziéde-Espariat

1

1 reference

25 July 2017

Damien Bresson

2

1 reference

25 July 2017

Marc Polivka

3

1 reference

25 July 2017

Schahrazed Bouazza

4

1 reference

25 July 2017

François Labrousse

5

1 reference

25 July 2017

Jean-Luc Pretet

7

1 reference

25 July 2017

Fabrice Projetti

8

1 reference

25 July 2017

Philippe Herman

9

1 reference

25 July 2017

Henri Salle

10

1 reference

25 July 2017

Séverine Valmary-Degano

12

1 reference

25 July 2017

Marc Pocard

14

1 reference

25 July 2017

Loïc Chaigneau

15

1 reference

25 July 2017

Nicolas Isambert

16

1 reference

25 July 2017

Sébastien Froelich

20

1 reference

25 July 2017

publication date

4 January 2016

1 reference

Journal of Neuropathology & Experimental Neurology

25 July 2017

published in

1 reference

25 July 2017

volume

75

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

111-120

1 reference

Building a global consensus approach to chordoma: a position paper from the medical and patient community

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Chordoma: current concepts, management, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Prognostic value of MIB-1, E-cadherin, and CD44 in pediatric chordomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Skull base chordomas: correlation of tumour doubling time with age, mitosis and Ki67 proliferation index

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Skull base and nonskull base chordomas: clinicopathologic and immunohistochemical study with special reference to nuclear pleomorphism and proliferative ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Chordomas and cartilaginous tumors at the skull base

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Chordoma and chondroid neoplasms of the spheno-occiput: An immunohistochemical study of 41 cases with prognostic and nosologic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Intracranial chordomas: a clinicopathological and prognostic study of 51 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Apoptotic and proliferative markers in chordomas: a study of 26 tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Immunohistochemical examination of proliferative potentials and the expression of cell cycle-related proteins of intracranial chordomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Analysis of immunohistochemical expression of p53 and the proliferation marker Ki-67 antigen in skull base chordomas: relationships between their expression and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

A comparison of cell-cycle markers in skull base and sacral chordomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Markers aiding the diagnosis of chondroid tumors: an immunohistochemical study including osteonectin, bcl-2, cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit), and YKL-40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Tyrosine kinase receptor expression in chordomas: phosphorylated AKT correlates inversely with outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

A multiplex SNaPshot assay as a rapid method for detecting KRAS and BRAF mutations in advanced colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Chordoma: incidence and survival patterns in the United States, 1973-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Prognostic value of MIB-1, p53, epidermal growth factor receptor, and INI1 in childhood chordomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Loss of SMARCB1/INI1 expression in poorly differentiated chordomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Anaplastic chordoma with loss of INI1 and brachyury expression in a 2-year-old girl

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromosomal loss involving CDKN2A, PTEN, and SMARCB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Expression of PTEN and mTOR in sacral chordoma and association with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2FNLV010

21 January 2018

Identifiers

DOI

10.1093/JNEN/NLV010

1 reference

25 July 2017

1 reference